This report shows patients by high and moderate risk as defined by ATAGI and utilised in the national roadmap.
It uses the same categories as the 'General' COVID-19 report:
- Dose 1 Categories
- Dose 1 Astrazeneca (Vaxzevria)
- Dose 1 Pfizer (Comirnaty)
- Dose 1 Unknown
- Dose 2 Categories
- Dose 2 Astrazeneca (Vaxzevria)
- Dose 2 Pfizer (Comirnaty)
- Dose 2 Unknown
- Not Recorded
But in this report only patients with underlying risk factors are reported along with their vaccine status.